Serum resistin, adiposity and insulin resistance in Saudi women with type 2 diabetes mellitus

Annals of Saudi Medicine

Volumn 25, Issue 4, 2005, Pages 283-287

  Al Harithy, Rowyda N ^a   Al Ghamdi, Shareefa ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; RESISTIN;

ADIPOCYTE; ADULT; AGED; ANTHROPOMETRY; ARTICLE; BODY HEIGHT; BODY WEIGHT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; SAUDI ARABIA; SIGNAL TRANSDUCTION;

EID: 24744468644     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.2005.283     Document Type: Article

References (28)

1. King H, Rewers M. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. WHO Ad Hoc Diabetes Reporting Group. Diabetes Care. 1993;16(1):157-77.
2. Jorgensen ME, Bjeregaard P, Borch-Johnsen K. Diabetes and impaired glucose tolerance among the inuit population of Greenland. Diabetes Care. 2002;25(10):1766-71.
3. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-53.
4. Pittas A, Joseph N, Greenberg A. Adipocytokines and insulin resistance. J Clin Endocrinol Metab. 2004;89(2):447-52.
5. Silha J, Krsek M, Skrha J, Sucharda P, Nyomba B, Murphy L. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol. 2003;149(4):331-5.
6. Steppan C, Brown E, Wright C, Bhat S, Banerjee R, Dai C, Enders G, Silberg D, Wen X, Wu G, Lazar M. A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci USA. 2001;98:502-506.
7. Steppan C, Bailey S, Bhat S, Brown E, Banerjee R, Wright C, Patel H, Ahima R, Lazar M. The hormone resistin links obesity to diabetes. Nature. 2001;409:307-312.
8. Savage D, Sewter C, Klenk E, Segal D, Vidal-Puig A, Considine R, O'Rahilly S. Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes 2001;50(10):2199-2202.
9. Yannakoulia M, Yiannakouris N, Blüher S, Matalas A, Klimis-Zacas D, Mantzoros C. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J Clin Endocrinol Metab. 2003;88(4):1730-1736.
10. Janke J, Engeli S, Gorzelniak K, Luft F, Sharma A. Resistin gone expression in human adipocytes is not related to insulin resistance. Obes Res. 2002;10(1):1-5.
11. Lee J, Chan J, Yiannakouris N, Kontogianni M, Estrada E, Seip R, Orlova C, Mantzoros C. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: Cross-sectional and interventional studies in normal, insulin-resistant and diabetic subjects. J Clin Endocrinol Metab. 2003;88(10):4848-4856.
12. McTernan C, McTernan P, Harte A, Levick P, Barnett A, Kumar S. Resistin, central obesity, and type 2 diabetes. Lancet. 2002;359(9300):46-47.
13. Al-Shammari S, Khoja T, Al-Maatouq M, Al-Nuaim L. High prevalence of clinical obesity among Saudi females: a prospective, cross-sectional study in the Riyadh region. J Trop Med Hyg. 1994;97:183-188.
14. Al-Nuaim A, Famuyiwa O, Greer W. Hyperlipidemia among Saudi diabetic patients-pattern and clinical characteristics. Ann Saudi Med. 1995;15(3):240-243.
15. Al-Nuaim A. Population-Based epidemiological study of the prevalence of overweight and obesity in Saudi Arabia, regional variation. Ann Saudi Med. 1997;17(2):195-199.
16. Mathews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985;28:412-419.
17. Azuma K, Katsukawa F, Oguchi S, Murata M, Yamazaki H, Shimada A, Saruta T. Correlation between serum resistin level and adiposity in obese individuals. Obes Res. 2003;11(8):997-1001.
18. Degawa-Yamauchi M, Bovenkerk J, Juliar B, Watson W, Kerr K, Jones R, Zhu Q, Considine R. Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab. 2003;88(11):5452-5455.
19. Youn B, Yu K, Park H, Lee N, Min S, Youn M, Cho Y, Park Y, Kim S, Lee H, Park K. Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2004;89(1):150-156.
20. Fujinami A, Obayashi H, Ohta K, Ichimura T, Nishimura M, Matsui H, Kawahara Y, Yamazaki M, Ogata M, Hasegawa G, Nakamura N, Yoshikawa T, Nakano K, Ohta, M. Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes. Clin Chim Acta. 2004;339(1-2):57-63.
21. Fehmann H, Heyn, J. Plasma resistin levels in patients with type 1 and type 2 diabetes mellitus and in healthy controls. Horm Metab Res. 2002;34(11-12):671-673.
22. Heilbronn L, Rood J, Janderova L, Albu J, Kelley D, Ravussin E, Smith, S. Relationship between Serum Resistin Concentrations and Insulin Resistance in Nonobese, Obese, and Obese Diabetic Subjects. J Clin Endocrinol Metab. 2004;89(4)1844-1848.
23. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman J. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425-32.
24. Juan C, Au L, Fang V, Kang S, Ko Y, Kuo S, Hsu Y, Kwok C, Ho L. Suppressed gene expression of adipocyte resistin in an insulin-resistant rat model probably by elevated free fatty acids. Biochem Biophys Res Commun. 2001;289(5):1328-33.
25. Levy J, Davenport B, Clore J, Stevens W. Lipid metabolism and resistin gene expression in insulin-resistant Fischer 344 rats. Am J Physiol Endocrinol Metab. 2002;282(3):E626-633.
26. Urbanek M, Du Y, Silander K, Collins F, Steppan C, Strauss J, Spielman R, Legro, R. Variation in resistin gene promoter not associated with polycystic ovary syndrome. Diabetes. 2003;52:214-217.
27. Kielstein J, Becker B, Graf S, Brabant G, Haller H, Fliser, D. Increased resistin blood levels are not associated with insulin resistance in patients with renal disease. Am J Kidney Dis. 2003;42(1):62-66.
28. Silha J, Krsek M, Hana V, Marek J, Jezkova J, Weiss V, Murphy L. Perturbations in adiponectin, leptin and resistin levels in acromegaly: lack of correlation with insulin resistance. Clin Endocrinol (Oxf). 2003;58(6):736-42.